Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials

BACKGROUND: The incidence of atrial fibrillation (AF) associated with anticancer drugs in cancer patients remains incompletely defined. OBJECTIVES: The primary outcome was the annualized incidence rate of AF reporting associated with exposure to 1 of 19 anticancer drugs used as monotherapy in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandre, Joachim, Boismoreau, Louis, Morice, Pierre-Marie, Sassier, Marion, Da-Silva, Angélique, Plane, Anne-Flore, Font, Jonaz, Milliez, Paul, Legallois, Damien, Dolladille, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Mini-Focus Issue: Bleeding, Thrombosis, and Atrial Fibrillation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152197/
https://www.ncbi.nlm.nih.gov/pubmed/37144106
http://dx.doi.org/10.1016/j.jaccao.2022.11.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152197/
https://www.ncbi.nlm.nih.gov/pubmed/37144106
http://dx.doi.org/10.1016/j.jaccao.2022.11.019

Ejemplares similares